Evaluation of health surveillance system attributes: the case of neglected tropical diseases in Kenya

Control of preventive chemotherapy-targeted neglected tropical diseases (PC-NTDs) depends on strengthened health techniques. Efficient health data techniques present an impetus to reaching the sustainable growth aim geared toward ending PC-NTD epidemics. However, there’s restricted evaluation of surveillance system capabilities linked to PC-NTDs and hinged on optimum efficiency of surveillance system attributes. The examine aimed to guage surveillance system attributes based mostly on healthcare staff’ perceptions in relation to PC-NTDs endemic in Kenya. A cross-sectional health facility survey was used to purposively pattern respondents concerned in illness surveillance actions.
Consenting respondents accomplished a self-administered questionnaire that assessed their perceptions on surveillance system attributes on a five-point likert scale. Frequency distributions for every level in the likert scale had been analysed to find out health staff’ general perceptions. Data was analysed utilizing descriptive statistics and estimated median values with corresponding interquartile ranges used to summarise reporting charges. Factor evaluation recognized variables measuring particular latent attributes. Pearson’s chi-square and Fisher’s precise checks examined associations between categorical variables. Thematic evaluation was carried out for questionnaire open-ended responses.
  Most (88%) respondents labored in public health amenities with 71% stationed in second-tier amenities. Regarding PC-NTDs, respondents perceived the surveillance system to be easy (55%), acceptable (50%), secure (41%), versatile (41%), helpful (51%) and to supply high quality knowledge (25%). Facility locality, facility sort, respondents’ schooling stage and years of work expertise had been related to perceived opinion on acceptability and stability respectively. Median month-to-month reporting timeliness and completeness charges for amenities had been 75 (58.3, 83.3) and 83.Three respectively.
Higher-level amenities met reporting timeliness (p < 0.001) and completeness (p < 0.001) thresholds in comparison with lower-level amenities.  Health personnel had decrease perceptions on the stability, flexibility and knowledge high quality of the surveillance system contemplating PC-NTDs. Reporting timeliness and completeness charges decreased in 2017 in comparison with earlier surveillance intervals. Strengthening all surveillance capabilities would affect health staff’ perceptions and enhance surveillance system general efficiency with regard to PC-NTDs.

An Overview of Current Uses and Future Opportunities for Computer-Assisted Design of Vaccines for Neglected Tropical Diseases

Neglected tropical diseases are infectious diseases that impose excessive morbidity and mortality charges over 1.5 billion individuals worldwide. Originally restricted to tropical and subtropical areas, altering local weather circumstances have elevated their potential to emerge elsewhere. Control of their impression suffers from shortages like poor epidemiological surveillance or irregular drug distribution, and a few NTDs nonetheless lack of acceptable diagnostics and/or environment friendly therapeutics. For these, availability of vaccines to forestall new infections, or the worsening of these already established, would imply a significant breakthrough.

However, solely dengue and rabies rely with permitted vaccines at current. Herein, we evaluate the state-of-the-art of vaccination methods for NTDs, setting the deal with third technology vaccines and the idea of reverse vaccinology. Its functionality to handle pathogens´ organic complexity, seemingly contributing to save lots of developmental prices is mentioned. The use of computational instruments is a elementary assist to research more and more massive datasets geared toward designing vaccine candidates with the highest, probably, alternatives to succeed. Ultimately, we determine and analyze these research that took an in silico method to search out vaccine candidates, and experimentally assessed their immunogenicity and/or safety capabilities.

Neglected tropical diseases (NTDs) are a various group of communicable diseases that principally impression the world’s poorest individuals. The use of digital health applied sciences is an rising and promising manner to enhance illness prevention, prognosis, case detection, therapy supply, and affected person follow-up and facilitating health facility appointments thereby bettering health outcomes. While the rising implementation of digital health applied sciences is clear, there’s a lack of complete proof on the impression of digital health applied sciences in the management of NTDs. The important goal of this evaluate was to map totally different items of proof on the use of digital health applied sciences for case detection, administration, and therapy end result of the neglected tropical illness.

Evaluation of health surveillance system attributes: the case of neglected tropical diseases in Kenya

Rethinking neglected tropical illness prevalence survey design and evaluation: a geospatial paradigm

Current strategies for the design and evaluation of neglected tropical illness prevalence surveys largely depend on classical survey sampling concepts that deal with prevalence knowledge from totally different places as an impartial random pattern from the chance distribution induced by a random sampling design. We set out an alternate, explicitly geospatial paradigm that may ship far more exact estimates of the geospatial variation in prevalence over a rustic or area of curiosity. We describe the benefits of this method below three headings: streamlining, whereby extra exact outcomes may be obtained with smaller pattern sizes; integrating, whereby a joint evaluation of knowledge from two or extra diseases can convey additional positive aspects in precision; and adapting, whereby the selection of future sampling location is knowledgeable by previous knowledge.

AZI2 antibody

70R-32139 100 ug
EUR 392.4
Description: Rabbit polyclonal AZI2 antibody

AZI2 Antibody

ABD3437 100 ug
EUR 525.6

AZI2 Antibody

ABF0553 100 ug
EUR 525.6

AZI2 Antibody

1-CSB-PA863992LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

AZI2 Antibody

CSB-PA596738- each
EUR 402
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

AZI2 Antibody

CSB-PA596738-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

AZI2 Antibody

1-CSB-PA003368
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000

AZI2 Antibody

DF3437 100ul
EUR 280
Description: Human,Mouse,Rat

AZI2 Antibody

AF0553 100ul
EUR 280
Description: Human,Mouse,Rat

AZI2 Antibody

8C11698 50ug
EUR 368
Description: AZI2 Antibody

AZI2 Antibody

E11-11698C 100μg
EUR 225
Description: Available in various conjugation types.

AZI2 Antibody

E034065 100μg/100μl
EUR 255
Description: Available in various conjugation types.

AZI2 Antibody

E314674 100ug/200ul
EUR 295
Description: Available in various conjugation types.

AZI2 Antibody

AF0553-100ul 100ul
EUR 280

AZI2 Antibody

AF0553-200ul 200ul
EUR 350

AZI2 Antibody

E18-0553-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

AZI2 Antibody

E18-0553-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

AZI2 Antibody

E19-3437 100μg/100μl
EUR 225
Description: Available in various conjugation types.

AZI2 Antibody

DF3437-100ul 100ul
EUR 280

AZI2 Antibody

DF3437-200ul 200ul
EUR 350

AZI2 Antibody

34065 100ul
EUR 319

anti- AZI2 antibody

FNab00758 100µg
EUR 606.3
Description: Antibody raised against AZI2

AZI2 Polyclonal Antibody

E917756 100ul
EUR 225
Description: Available in various conjugation types.

AZI2 Antibody, HRP conjugated

1-CSB-PA863992LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

AZI2 Antibody, FITC conjugated

1-CSB-PA863992LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

AZI2 Antibody, Biotin conjugated

1-CSB-PA863992LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against AZI2. Recognizes AZI2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

ARP62739_P050-25UL - AZI2 Antibody - middle region

ARP62739_P050-25UL 25ul
EUR 99

ARP82954_P050 - AZI2 Antibody-N-terminal region

ARP82954_P050 100ul
EUR 389

ARP62739_P050 - AZI2 antibody - middle region (ARP62739_P050)

ARP62739_P050 100ul
EUR 389

5-Azacytidine-Induced Protein 2 (AZI2) Antibody

abx230758-100ug 100 ug
EUR 577.2

5-Azacytidine-Induced Protein 2 (AZI2) Antibody

abx332767-100ul 100 ul
EUR 510

5-Azacytidine-Induced Protein 2 (AZI2) Antibody

20-abx333820
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

5-Azacytidine-Induced Protein 2 (AZI2) Antibody

20-abx013797
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

5-Azacytidine-Induced Protein 2 (AZI2) Antibody

20-abx329457
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

OASG04831-100UL - AZI2 Antibody - N-terminal region

OASG04831-100UL 100ul
EUR 239

ARP74410_P050-25UL - AZI2 Antibody - C-terminal region

ARP74410_P050-25UL 25ul
EUR 99

ARP82954_P050-25UL - AZI2 Antibody - N-terminal region

ARP82954_P050-25UL 25ul
EUR 99

ARP62738_P050-25UL - AZI2 Antibody - N-terminal region

ARP62738_P050-25UL 25ul
EUR 99

ARP74410_P050 - AZI2 Antibody - C-terminal region (ARP74410_P050)

ARP74410_P050 100ul
EUR 389

ARP62738_P050 - AZI2 antibody - N-terminal region (ARP62738_P050)

ARP62738_P050 100ul
EUR 389

5-Azacytidine-Induced Protein 2 (AZI2) Antibody (HRP)

20-abx334503
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

5-Azacytidine-Induced Protein 2 (AZI2) Antibody (FITC)

20-abx334504
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

5-Azacytidine-Induced Protein 2 (AZI2) Antibody (Biotin)

20-abx334505
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Azi2/ Rat Azi2 ELISA Kit

ELI-33379r 96 Tests
EUR 1063.2

AZI2 siRNA

20-abx908745
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

AZI2 siRNA

20-abx908746
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

AZI2 siRNA

20-abx900565
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Anti-AZI2 Antibody

A08235 100ul
EUR 476.4
Description: Rabbit Polyclonal AZI2 Antibody. Validated in WB and tested in Human, Mouse, Rat.

Anti-AZI2 antibody

PAab00758 100 ug
EUR 426

AZI2 Rabbit mAb

A21159 1000μL
EUR 232.7
Description: Recombinant protein of human CD28 Full length(P10747)

AZI2 Rabbit mAb

E2R23577 100ul
EUR 255
Description: Available in various conjugation types.

AZI2 Rabbit mAb

52169 100ul
EUR 499

AZI2 Rabbit mAb

60199 100ul
EUR 339

AZI2 Blocking Peptide

AF0553-BP 1mg
EUR 234

AZI2 Blocking Peptide

DF3437-BP 1mg
EUR 234

Azi2 (untagged ORF) - Rat 5-azacytidine induced 2 (Azi2), (10 ug)

RN205746 10 µg Ask for price

AZI2 ELISA KIT|Human

EF008030 96 Tests
EUR 826.8

Rat AZI2 shRNA Plasmid

20-abx989925
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse AZI2 shRNA Plasmid

20-abx973842
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human AZI2 shRNA Plasmid

20-abx961990
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

AZI2 (untagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 3

SC325639 10 µg Ask for price

AZI2 (untagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 2

SC325655 10 µg Ask for price

AZI2 (untagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 1

SC112480 10 µg Ask for price

AZI2 (untagged) - Human 5-azacytidine induced 2 (AZI2), transcript variant 4

SC335036 10 µg Ask for price

AZI2 Recombinant Protein (Rat)

RP191693 100 ug Ask for price

AZI2 Recombinant Protein (Mouse)

RP118415 100 ug Ask for price

AZI2 Recombinant Protein (Mouse)

RP118418 100 ug Ask for price

AZI2 Recombinant Protein (Human)

RP048181 100 ug Ask for price

AZI2 (GFP-tagged) - Human 5-azacytidine induced 2 (AZI2), transcript variant 1

RG211435 10 µg Ask for price

AZI2 (GFP-tagged) - Human 5-azacytidine induced 2 (AZI2), transcript variant 3

RG225290 10 µg Ask for price

AZI2 (GFP-tagged) - Human 5-azacytidine induced 2 (AZI2), transcript variant 2

RG225310 10 µg Ask for price

Azi2 (untagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 3

MC225905 10 µg Ask for price

Azi2 (untagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 4

MC227522 10 µg Ask for price

Azi2 (Myc-DDK-tagged ORF) - Rat 5-azacytidine induced 2 (Azi2), (10 ug)

RR205746 10 µg Ask for price

Azi2 ORF Vector (Rat) (pORF)

ORF063899 1.0 ug DNA
EUR 607.2

AZI2 ORF Vector (Human) (pORF)

ORF016061 1.0 ug DNA Ask for price

Azi2 ORF Vector (Mouse) (pORF)

ORF039473 1.0 ug DNA
EUR 607.2

Azi2 ORF Vector (Mouse) (pORF)

ORF039474 1.0 ug DNA
EUR 607.2

Human AZI2 knockout cell line

ABC-KH1268 1 vial Ask for price
Description: Human AZI2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Rabbit polyclonal anti-AZI2 antibody

TA315727 100 µl Ask for price

Rabbit Polyclonal Anti-AZI2 Antibody

TA347658 100 µg Ask for price

AZI2 ELISA Kit (Human) (OKEH07990)

OKEH07990 96 Wells
EUR 1075.2
Description: Description of target: AZI2, or NAP1, contributes to the activation of NFKB (see MIM 164011)-dependent gene expression by activating IKK-related kinases, such as NAK (TBK1; MIM 604834) (Fujita et al., 2003 [PubMed 14560022]).[supplied by OMIM, Mar 2008];Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.093ng/mL

Human AZI2 Protein Lysate 20ug

IHUAZI2PLLY20UG each
EUR 213
Description: Human AZI2 Protein Lysate 20ug

Human AZI2 knockdown cell line

ABC-KD1268 1 vial Ask for price
Description: Human AZI2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

AZI2 (Myc-DDK-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 1

RC211435 10 µg Ask for price

AZI2 (myc-DDK-tagged) - Human 5-azacytidine induced 2 (AZI2), transcript variant 4

RC237142 10 µg Ask for price

AZI2 (Myc-DDK-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 3

RC225290 10 µg Ask for price

AZI2 (Myc-DDK-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 2

RC225310 10 µg Ask for price

Azi2 (untagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 1, (10ug)

MC200564 10 µg Ask for price

Azi2 (GFP-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 1

MG206364 10 µg Ask for price

OCOA08600-20UG - AZI2 Protein Lysate

OCOA08600-20UG 20ug
EUR 169

Azi2 (myc-DDK-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 4

MR229733 10 µg Ask for price

Azi2 (Myc-DDK-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 2

MR216061 10 µg Ask for price

Azi2 (myc-DDK-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 3

MR228116 10 µg Ask for price

Azi2 (GFP-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2) transcript variant 2, (10ug)

MG216061 10 µg Ask for price

Azi2 (Myc-DDK-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 1

MR206364 10 µg Ask for price

OKEH07990-96W - AZI2 ELISA Kit (Human)

OKEH07990-96W 96Wells
EUR 725

Azi2 sgRNA CRISPR Lentivector set (Rat)

K7135801 3 x 1.0 ug
EUR 406.8

AZI2 sgRNA CRISPR Lentivector set (Human)

K0162101 3 x 1.0 ug
EUR 406.8

Azi2 sgRNA CRISPR Lentivector set (Mouse)

K3190301 3 x 1.0 ug
EUR 406.8

Lenti ORF clone of Azi2 (mGFP-tagged ORF) - Rat 5-azacytidine induced 2 (Azi2), (10 ug)

RR205746L4 10 µg Ask for price

AAP62739-100UG - AZI2 Peptide - middle region

AAP62739-100UG 100ug
EUR 99

Lenti-ORF clone of AZI2 (mGFP-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 3

RC225290L4 10 µg Ask for price

Lenti-ORF clone of AZI2 (mGFP-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 2

RC225310L4 10 µg Ask for price

Lenti ORF clone of Azi2 (Myc-DDK-tagged ORF) - Rat 5-azacytidine induced 2 (Azi2), (10 ug)

RR205746L3 10 µg Ask for price

Azi2 3'UTR GFP Stable Cell Line

TU152443 1.0 ml Ask for price

AZI2 3'UTR GFP Stable Cell Line

TU051559 1.0 ml
EUR 1825.2

Azi2 3'UTR GFP Stable Cell Line

TU251164 1.0 ml Ask for price

Lenti ORF particles, Azi2 (GFP-tagged ORF) - Rat 5-azacytidine induced 2 (Azi2), 200ul, >10^7 TU/mL

RR205746L4V 200 µl Ask for price

AZI2 Protein Vector (Rat) (pPM-C-HA)

PV255596 500 ng
EUR 723.6

AZI2 Protein Vector (Rat) (pPB-C-His)

PV255594 500 ng
EUR 723.6

AZI2 Protein Vector (Rat) (pPB-N-His)

PV255595 500 ng
EUR 723.6

AZI2 Protein Vector (Rat) (pPM-C-His)

PV255597 500 ng
EUR 723.6

AZI2 Protein Vector (Human) (pPM-C-HA)

PV064243 500 ng Ask for price

AZI2 Protein Vector (Mouse) (pPM-C-HA)

PV157892 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPM-C-HA)

PV157896 500 ng
EUR 723.6

Lenti ORF clone of Azi2 (mGFP-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 2

MR216061L4 10 µg Ask for price

Lenti ORF clone of Azi2 (mGFP-tagged) - Mouse 5-azacytidine induced gene 2 (Azi2), transcript variant 1

MR206364L4 10 µg Ask for price

AZI2 Protein Vector (Human) (pPB-C-His)

PV064241 500 ng Ask for price

AZI2 Protein Vector (Human) (pPB-N-His)

PV064242 500 ng Ask for price

AZI2 Protein Vector (Human) (pPM-C-His)

PV064244 500 ng Ask for price

AZI2 Protein Vector (Mouse) (pPB-C-His)

PV157890 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPB-N-His)

PV157891 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPM-C-His)

PV157893 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPB-C-His)

PV157894 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPB-N-His)

PV157895 500 ng
EUR 723.6

AZI2 Protein Vector (Mouse) (pPM-C-His)

PV157897 500 ng
EUR 723.6

AZI2 3'UTR Luciferase Stable Cell Line

TU001559 1.0 ml
EUR 1825.2

Azi2 3'UTR Luciferase Stable Cell Line

TU102443 1.0 ml Ask for price

Azi2 3'UTR Luciferase Stable Cell Line

TU201164 1.0 ml Ask for price

Lenti-ORF clone of AZI2 (Myc-DDK-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 3

RC225290L3 10 µg Ask for price

Lenti-ORF clone of AZI2 (Myc-DDK-tagged)-Human 5-azacytidine induced 2 (AZI2), transcript variant 2

RC225310L3 10 µg Ask for price

AZI2 Protein Vector (Human) (pPB-His-MBP)

PV325866 500 ng Ask for price

AZI2 Protein Vector (Human) (pPB-His-GST)

PV325867 500 ng Ask for price

Azi2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7135802 1.0 ug DNA
EUR 184.8

Azi2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7135803 1.0 ug DNA
EUR 184.8

Azi2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7135804 1.0 ug DNA
EUR 184.8
A complete of 996 probably related research had been generated from the preliminary search, and 6 research had been discovered to fulfill all the inclusion standards and included in the last evaluate. The evaluate discovered that telehealth, eHealth, mHealth, telemedicine, and digital health file had been used digital health applied sciences to evaluate their impression on case detection, illness administration, and therapy end result of neglected tropical diseases. Mobile health was a possible digital health know-how for lymphatic filariasis affected person identification and mHealth, eHealth, and digital health information discovered to enhance the service entry, outcomes, and monitoring of visceral leishmaniasis at the neighborhood health system.